Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Nephros (NEPH) Short-Term Debt issuances (2017 - 2020)

Nephros has reported Short-Term Debt issuances over the past 4 years, most recently at -$495000.0 for Q2 2020.

  • Quarterly results put Short-Term Debt issuances at -$495000.0 for Q2 2020, down 530.43% from a year ago — trailing twelve months through Jun 2020 was -$530000.0 (down 161.06% YoY), and the annual figure for FY2019 was -$431000.0, down 253.93%.
  • Short-Term Debt issuances for Q2 2020 was -$495000.0 at Nephros, down from -$65000.0 in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for NEPH hit a ceiling of $828000.0 in Q4 2018 and a floor of -$561000.0 in Q1 2018.
  • Median Short-Term Debt issuances over the past 4 years was $3000.0 (2018), compared with a mean of -$11333.3.
  • Biggest five-year swings in Short-Term Debt issuances: surged 3733.33% in 2019 and later plummeted 530.43% in 2020.
  • Nephros' Short-Term Debt issuances stood at $148000.0 in 2017, then skyrocketed by 459.46% to $828000.0 in 2018, then tumbled by 86.11% to $115000.0 in 2019, then plummeted by 530.43% to -$495000.0 in 2020.
  • The last three reported values for Short-Term Debt issuances were -$495000.0 (Q2 2020), -$65000.0 (Q1 2020), and $115000.0 (Q2 2019) per Business Quant data.